Agenda


Day 1 – March 19th


8:00-8:20- Registration & Breakfast

8:20-8:45- Welcome Remarks (Tulane University School of Medicine: Greg Bix, Director, CNRC; Lee Hamm, Dean, School of Medicine)

8:45-9:30- The year that was: Clinical and scientific advancements in translational stroke in 2019 (S. Thomas Carmichael, UCLA)

9:30-10:15- There and back again: Lessons from the natalizumab experience (Kyra Becker, University of Washington)

10:15-10:45- Coffee Break

10:45-11:30- Consideration of Ageing in Ischemic Stroke (Miguel Perez Pinzon, University of Miami)

11:30-12:15- Sex, Microbiome and Stroke (Louise McCullough, University of Texas, Houston)

12:15-12:30- Tulane Brain Institute (Jill Daniel, Director, Tulane Brain Institute)

12:30-1:45- Networking Lunch at Themed Tables (Tulane University: Greg Bix, Xiaoying Wang, Prasad Katakam, David Busija)

3:00- Board Buses for Afternoon Activities


AFTERNOON DESTINATION ACTIVITY


3:30-5:00- Mardi Gras World tour

5:15-8:00- Tour & Dinner at Tulane President’s house


Day 2 – March 20th


8:00-8:30- Breakfast and Announcements (Tulane University School of Medicine: Greg Bix, Director, CNRC)

8:30-8:45- Research at Tulane University (Giovanni Piedimonte, Vice President for Research, Tulane University)

8:45-9:30- Beyond Motor Recovery: Post-stroke dementia (Marion Buckwalter, Stanford University)

9:30-10:15- Consideration of systemic responses in stroke (Eng Lo, Harvard Medical School)

10:15-10:45- Coffee Break

11:00-12:15- Interactive Brainstorming – what’s wrong with translational stroke research and how can we fix it? (Cenk Ayata, Harvard Medical School)

12:15-12:30- Research at Tulane School of Medicine (Patrice Delafontaine, Executive Dean, Tulane School of Medicine)

12:30-1:30- Lunch seminar – How to translate science to therapy from an Industry perspective (Gary Gage, Stream Biomedical)

1:30-4:00- Workgroups for paper publication


  • Participants are invited to remain for the afternoon to help draft possible publications from the Workshop. 
  • Groups will form around particular topics, discuss recommendations and concrete methods for moving the field forward. 
  • Writing groups will be formed to continue the work after the meeting.

The following subjects will be discussed in three workgroups:

  • Novel methods and protocols in ischemic stroke
  • Stroke biomarkers
  • Drug repurposing in ischemic stroke treatment